日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Efficacy and Safety of Atezolizumab Plus Bevacizumab for Patients With Hepatocellular Carcinoma and Child-Pugh Class B

阿特珠单抗联合贝伐珠单抗治疗Child-Pugh B级肝细胞癌患者的疗效和安全性

期刊:Liver International
影响因子:5.2
doi:10.1111/liv.70466
Sasaki, Ryu; Shimose, Shigeo; Saeki, Issei; Ito, Takanori; Takeuchi, Yasuto; Tani, Joji; Tomonari, Tetsu; Sasaki, Kyo; Kakizaki, Satoru; Hatanaka, Takeshi; Miuma, Satoshi; Shirono, Tomotake; Iwamoto, Hideki; Tanabe, Norikazu; Yamamoto, Takafumi; Kanayama, Yuki; Naganuma, Atsushi; Nishina, Sohji; Takayama, Tetsuji; Kobara, Hideki; Otsuka, Motoyuki; Kawashima, Hiroki; Takami, Taro; Kawaguchi, Takumi; Miyaaki, Hisamitsu
细胞生物学
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Outcomes of Sequential Immune Checkpoint Inhibitor Retreatment After Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma

阿特珠单抗联合贝伐珠单抗治疗不可切除肝细胞癌患者后序贯免疫检查点抑制剂再治疗的疗效

期刊:Journal of Gastroenterology and Hepatology
影响因子:3.4
doi:10.1111/jgh.70150
Ito, Takanori; Shimose, Shigeo; Saeki, Issei; Takeuchi, Yasuto; Tani, Joji; Tomonari, Tetsu; Sasaki, Ryu; Sasaki, Kyo; Kakizaki, Satoru; Hatanaka, Takeshi; Iwamoto, Hideki; Tanabe, Norikazu; Yamamoto, Takafumi; Naganuma, Atsushi; Shirono, Tomotake; Kanayama, Yuki; Miyaaki, Hisamitsu; Nishina, Sohji; Takayama, Tetsuji; Kobara, Hideki; Otsuka, Motoyuki; Takami, Taro; Kawaguchi, Takumi; Kawashima, Hiroki
Checkpoint
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2026
文献求助 收藏

Acidic Microenvironment Enhances Cisplatin Resistance in Bladder Cancer via Bcl-2 and XIAP

酸性微环境通过 Bcl-2 和 XIAP 增强膀胱癌的顺铂耐药性

期刊:Current Issues in Molecular Biology
影响因子:3
doi:10.3390/cimb47010043
Hiruma, Kaede; Bilim, Vladimir; Kazama, Akira; Shirono, Yuko; Murata, Masaki; Tomita, Yoshihiko
Bcl-2
肿瘤
肿瘤免疫
XIAP
膀胱癌
发表日期：2025
文献求助 收藏

Essential Safety Considerations for Total Hip Arthroplasty: Pelvic and Spine Alignment Across Age Groups in Women at an Osteoporosis Outpatient Clinic-A Retrospective Observational Study

全髋关节置换术的关键安全考量：骨质疏松症门诊女性不同年龄组的骨盆和脊柱排列——一项回顾性观察研究

期刊:Journal of Clinical Medicine
影响因子:2.9
doi:10.3390/jcm14061847
Shirono, Makoto; Imai, Norio; Homma, Daisuke; Hirano, Yuki; Horigome, Yoji; Kawashima, Hiroyuki
代谢
骨质疏松
发表日期：2025
文献求助 收藏

Lenvatinib versus sorafenib as second-line therapy following progression on atezolizumab-bevacizumab in patients with unresectable hepatocellular carcinoma: a multicenter retrospective study from Korea and Japan

在不可切除的肝细胞癌患者中，阿特珠单抗-贝伐珠单抗治疗进展后，乐伐替尼与索拉非尼作为二线治疗的比较：一项来自韩国和日本的多中心回顾性研究

期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-025-06085-1
Cheon, Jaekyung; Shimose, Shigeo; Kim, Hyung-Don; Niizeki, Takashi; Ryu, Min-Hee; Shirono, Tomotake; Ryoo, Baek-Yeol; Iwamoto, Hideki; Yoo, Changhoon
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

A Rare Case of Undifferentiated Carcinoma of the Liver Arising in the Context of Primary Biliary Cholangitis

原发性胆汁性胆管炎背景下发生的罕见肝脏未分化癌病例报告

期刊:Internal Medicine
影响因子:1.1
doi:10.2169/internalmedicine.4177-24
Suzuki, Hiroyuki; Shirono, Tomotake; Niizeki, Takashi; Sugawara, Shuhei; Kusano, Hironori; Kondo, Reiichiro; Akiba, Jun; Kawaguchi, Takumi
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

A Rare Case of Primary Hepatic Undifferentiated Pleomorphic Sarcoma: Exploring Cancer-related Gene Mutations

一例罕见的原发性肝脏未分化多形性肉瘤：探索癌症相关基因突变

期刊:Internal Medicine
影响因子:1.1
doi:10.2169/internalmedicine.4368-24
Suzuki, Hiroyuki; Fukuda, Michitaka; Shirono, Tomotake; Kondo, Reiichiro; Tanaka, Toshimitsu; Niizeki, Takashi; Akiba, Jun; Koga, Hironori; Kawaguchi, Takumi
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Pigmented perivascular epithelioid cell tumors of the orbit with NONO::TFE3 fusion: Molecular evaluation and literature review

伴有NONO::TFE3融合基因的眼眶色素性血管周围上皮样细胞肿瘤：分子评估和文献综述

期刊:American Journal of Ophthalmology Case Reports
影响因子:
doi:10.1016/j.ajoc.2025.102378
Takeda-Miyata, Naoko; Yoshida, Ken-Ichi; Shirono, Miho; Watanabe, Akihide; Kukita, Yoji; Sotozono, Chie; Konishi, Eiichi
肿瘤
肿瘤免疫
TFE3
细胞生物学
NONO
发表日期：2025
文献求助 收藏

Efficacy of Atezolizumab Plus Bevacizumab-Transcatheter Arterial Chemoembolization Sequential Therapy for Patients with Intermediate-Stage Hepatocellular Carcinoma

阿特珠单抗联合贝伐珠单抗-经导管动脉化疗栓塞序贯疗法治疗中晚期肝细胞癌患者的疗效

期刊:Current Oncology
影响因子:3.4
doi:10.3390/curroncol31100432
Moriyama, Etsuko; Shimose, Shigeo; Niizeki, Takashi; Iwamoto, Hideki; Tanaka, Masatoshi; Shirono, Tomotake; Noda, Yu; Nakano, Masahito; Kuromatsu, Ryoko; Koga, Hironori; Kawaguchi, Takumi
细胞生物学
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Selective HDAC6 Inhibition Has the Potential for Anti-Cancer Effect in Renal Cell Carcinoma

选择性 HDAC6 抑制对肾细胞癌具有抗癌作用

期刊:Journal of Personalized Medicine
影响因子:3
doi:10.3390/jpm14070704
Tsutomu Anraku, Masaki Murata, Hiroo Kuroki, Akira Kazama, Yuko Shirono, Masayuki Tasaki, Vladimir Bilim, Yoshihiko Tomita
肿瘤
肾癌
其它细胞
发表日期：2024
文献求助 收藏